» Articles » PMID: 16019900

Effect of Surfactant HLB and Different Formulation Variables on the Properties of Poly-D,L-lactide Microspheres of Naltrexone Prepared by Double Emulsion Technique

Overview
Journal J Microencapsul
Publisher Informa Healthcare
Date 2005 Jul 16
PMID 16019900
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this work was to investigate the role of HLB of emulsifier as well as volume of the internal aqueous phase (W(1)) and presence of salt in the external aqueous phase (W(2)) on the morphology, size and encapsulation efficiency of poly(D,L-lactide) microspheres containing naltrexone HCl. PLA microparticles containing naltrexone HCl, an effective opiate antagonist, were prepared by a water-in-oil-in-water emulsification-solvent evaporation procedure. One of the five different emulsifiers: span 80, span 20, tween 85, tween 80 and tween 20, with HLB values from 4-17 were added to W(1). Presence of emulsifier in W(1) resulted in smaller particles with a more dense and uniform internal structure. Incorporation of span 80 (HLB 4.3, suitable for W/O emulsions) yield the highest encapsulation efficiency. Increasing the HLB value to 8 or 11 (span 20 or tween 85) decreased the efficiency of naltrexone HCl-loading. HLB values higher than 15 (tween 80 or tween 20) increased encapsulation efficiency unexpectedly, which could be attributed to migration of these emulsifiers to the O/W(2) interface and modifying the surface properties of microparticles. Increasing the internal water phase volume from 0.2-1.8 ml resulted in larger particle size with poor encapsulation efficiency. Addition of 10% w/w NaCl to the W(2) changed the surface morphology of microspheres from a porous form to a smooth surface. It was shown that, by selecting the appropriate HLB value of emulsifier in W(1), addition of salt to W(2) and controlling the volume of W(1), one can control the encapsulation efficiency, size and morphology of microspheres.

Citing Articles

Olive oil and castor oil-based self-nanoemulsifying drug delivery system of flurbiprofen can relieve peripheral pain and inflammation through reduction of oxidative stress and inflammatory biomarkers: a comprehensive formulation and pharmacological....

Basar M, Khan M, Akhtar M, Anwar F, Saleem A, Madni A Inflammopharmacology. 2025; 33(1):353-379.

PMID: 39776028 DOI: 10.1007/s10787-024-01632-7.


Formulation and optimisation of bedaquiline nanoemulsions for the potential treatment of multi drug resistant tuberculosis in paediatrics using quality by design.

Ajayi T, Poka M, Witika B Sci Rep. 2024; 14(1):31891.

PMID: 39738619 PMC: 11686176. DOI: 10.1038/s41598-024-83408-1.


Formulation of nanoemulsion parijoto fruit extract () with variation of tweens stabilizers.

Ananingsih V, Pratiwi A, Soedarini B, Putra Y Front Nutr. 2024; 11:1398809.

PMID: 39040928 PMC: 11262260. DOI: 10.3389/fnut.2024.1398809.


The Fatty Acid Compositions, Irritation Properties, and Potential Applications of Oil in Nanoemulsion Development.

Chaiyana W, Inthorn J, Somwongin S, Anantaworasakul P, Sopharadee S, Yanpanya P Nanomaterials (Basel). 2024; 14(2).

PMID: 38251148 PMC: 10818487. DOI: 10.3390/nano14020184.


Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.

Yang R, Zhang G, Zemlyanov D, Purohit H, Taylor L Pharm Res. 2023; 40(12):2817-2845.

PMID: 37052841 DOI: 10.1007/s11095-023-03502-3.